The DOI matches its Crossref record; 97 of the 98 references it cites were found in a registry or an index; none of the 51 sources its claims cite is checked for support yet.
Pathological mutations in the phospholamban cytoplasmic region affect its topology and dynamics modulating the extent of SERCA inhibition
Open accessAbstract
Phospholamban (PLN) is a 52 amino acid regulin that allosterically modulates the activity of the sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA) in the heart muscle. In its unphosphorylated form, PLN binds SERCA within its transmembrane (TM) domains, approximately 20 Å away from the Ca2+ binding site, reducing SERCA’s apparent Ca2+ affinity (pKCa) and decreasing cardiac contractility. During the enzymatic cycle, the inhibitory TM domain of PLN remains anchored to SERCA, whereas its cytoplasmic region transiently binds the ATPase’s headpiece. Phosphorylation of PLN at Ser16 by protein kinase A increases the affinity of its cytoplasmic domain to SERCA, weakening the TM interactions with the ATPase, reversing its inhibitory function, and augmenting muscle contractility. How the structural changes caused by pathological mutations in the PLN cytoplasmic region are transmitted to its inhibitory TM domain is still unclear. Using solid-state NMR spectroscopy and activity assays, we analyzed structural and functional effects of a series of mutations and their phosphorylated forms located in the PLN cytoplasmic region and linked to dilated cardiomyopathy. We found that these missense mutations affect the overall topology and dynamics of PLN and ultimately modulate its inhibitory potency. Also, the changes in the TM tilt angle and cytoplasmic dynamics of PLN caused by these mutations correlate well with the extent of SERCA inhibition. Our study unveils new molecular determinants for designing variants of PLN that outcompete endogenous PLN to regulate SERCA in a tunable manner.
Overview
CoChat Summary
TL;DR
Using solid-state NMR and activity assays, the authors show that dilated cardiomyopathy-linked mutations in the phospholamban cytoplasmic domain alter PLN topology and dynamics, and that these changes correlate with the extent of SERCA inhibition. TM tilt angle and cytoplasmic dynamics emerge as structural determinants of PLN inhibitory potency.
Key findings
- DCM mutations in PLN domain Ia (R9C, R9H, R9L, R25C) change PLN topology and dynamics. For wild-type PLN, the inhibitory orientation has θ = 37.2 ± 0.8° and ρL31 = 198 ± 4°; S16 phosphorylation shifts it to a non-inhibitory state with θ = 35 ± 1° and ρL31 = 200 ± 3°, while RlpCP/CP increases from 20 ± 2% to 49 ± 2%.
- PLNR9H, PLNR25C, PLNR9C, and PLNR9L show altered tilt/rotation and dynamics: PLNR9H shifts from θ = 37 ± 1° to 35.4 ± 0.9° upon phosphorylation; PLNR25C shifts from θ = 39 ± 1° to 36 ± 1°; PLNR9C has θ = 38 ± 1°; PLNR9L has θ = 39 ± 1°. RlpCP/CP values were 179 ± 24% → 186 ± 19% for R9H, 9 ± 1% → 32 ± 4% for R25C, 24 ± 2% for R9C, and 7 ± 1% for R9L.
- In activity assays, pPLNR9H, pPLNR9L, and pPLNR25C had roughly identical ATPase activities and ΔpKCa values; the exception was pPLNR9C, whose S16 phosphorylation did not completely reverse SERCA inhibition.
- ΔpKCa correlated with RlpCP/CP with R² = 0.54 (two-tailed p = 0.051) except for PLNR9H and pPLNR9H outliers, and correlated better with TM tilt angle with R² = 0.62 (two-tailed p = 0.012), indicating larger tilt angles are more inhibitory.
Methods
- Oriented-sample solid-state NMR used a cysteine-null monomeric PLN background (C36A, C41F, C46A) with R9C, R9H, R9L, R25C, or R14del substitutions; proteins were expressed in E. coli, purified, phosphorylated with PKA, and verified by MALDI-MS. Samples were reconstituted in magnetically oriented DMPC:POPC/DHPC bicelles (q = 4.0, 5 mM Yb³⁺, pH 4.2, 27 °C) and analyzed on a 700 MHz Varian VNMRS using SE-SAMPI4, 1D CP, and low-power CP experiments; PISA-SPARKY fits yielded tilt, azimuthal, and order parameters, and RlpCP/CP ratios.
- SERCA activity assays used SERCA1a purified from rabbit skeletal muscle, co-reconstituted with PLN or mutants at a 5:1 molar ratio in DOPC:DOPE (4:1; 2500:1 lipid:SERCA). Enzyme-coupled NADH assays were run at pCa 8.0–5.0, and Hill fits extracted Vmax, Vmin, and pKCa; assays were done in triplicate.
Limitations
- The paper states that it used the AFA monomeric PLN species to avoid monomer–pentamer equilibrium complications, but notes that AFA is a slight gain-of-function mutant with limitations as a functional model; future work will analyze monomer–pentamer equilibrium.
- The paper states that PLNR9C bicelle preparations were unstable, and phosphorylation of PLNR9C and PLNR9L increased aggregation, preventing well-aligned bicelles for NMR analysis.
- Evident from the text: the correlations are moderate (R² = 0.54 and 0.62) and R9H/pR9H are outliers; functional assays used skeletal-muscle SERCA1a rather than cardiac SERCA2a, and R14del appears in Methods but no results are reported for it.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 Valid · 0 Not valid · 32 Not checked · 51 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Specifically, we found that SERCA’s apparent Ca2+ affinity of these missense variants correlates well with both the extent of the conformational dynamics of their cytoplasmic domains and their TM tilt angles.”
§ Pathological Mutations in the Phospholamban Cytoplasmic Region Affect its Topology and Dynamics Modulating the Extent of SERCA Inhibition > Introduction
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We found that these missense mutations affect the overall topology and dynamics of PLN and ultimately modulate its inhibitory potency.”
- Also stated in: § Introduction · plain
“We found that these mutations affect both the conformational dynamics and the TM orientation (i.e., rotation and tilt angles) of PLN, modulating the extent of SERCA inhibition.”
§ Pathological Mutations in the Phospholamban Cytoplasmic Region Affect its Topology and Dynamics Modulating the Extent of SERCA Inhibition > Abstract
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Introduction · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Specifically, we found that SERCA’s apparent Ca2+ affinity of these missense variants correlates well with both the extent of the conformational dynamics of their cytoplasmic domains and their TM tilt angles.”
§ Pathological Mutations in the Phospholamban Cytoplasmic Region Affect its Topology and Dynamics Modulating the Extent of SERCA Inhibition > Introduction
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Also, the changes in the TM tilt angle and cytoplasmic dynamics of PLN caused by these mutations correlate well with the extent of SERCA inhibition.”
§ Pathological Mutations in the Phospholamban Cytoplasmic Region Affect its Topology and Dynamics Modulating the Extent of SERCA Inhibition > Abstract
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We found that these missense mutations affect the overall topology and dynamics of PLN and ultimately modulate its inhibitory potency.”
- Also stated in: § Introduction · plain
“We found that these mutations affect both the conformational dynamics and the TM orientation (i.e., rotation and tilt angles) of PLN, modulating the extent of SERCA inhibition.”
§ Pathological Mutations in the Phospholamban Cytoplasmic Region Affect its Topology and Dynamics Modulating the Extent of SERCA Inhibition > Abstract
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Introduction · plain
42 more claims
Create a free account to see all 83 claims and to verify the 51 references still open.
- It may state two separate claims as one. 26
- Probably not a substantial claim. 18
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Pathological Mutations in the Phospholamban Cytoplasmic Region Affect its Topology and Dynamics Modulating the Extent of SERCA Inhibition > Materials and Methods > Bicelle preparation for oriented-sample solid state NMR studies
“sample buffer (20 mM HEPES, 100 mM KCl, 1 mM NaN3, pH 6.5)”
§ Pathological Mutations in the Phospholamban Cytoplasmic Region Affect its Topology and Dynamics Modulating the Extent of SERCA Inhibition > Materials and Methods > Bicelle preparation for oriented-sample solid state NMR studies
“20 mM HEPES, 100 mM NaCl, 1 mM NaN3, and 1 mM TCEP”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Pathological Mutations in the Phospholamban Cytoplasmic Region Affect its Topology and Dynamics Modulating the Extent of SERCA Inhibition > Materials and Methods > Cloning, expression, purification, and phosphorylation of PLN variants
“The active cysteine-null monomeric mutant of PLN (C36A, C41F, C46A)”
§ Pathological Mutations in the Phospholamban Cytoplasmic Region Affect its Topology and Dynamics Modulating the Extent of SERCA Inhibition > Results > DCM mutations affect the dynamics and topology of PLN in membrane bilayers.
“the three TM cysteines (Cys36, Cys 41, and Cys42) were mutated into Ala, Phe, and Ala, respectively”
Citations
Cites
NMRPipe: A multidimensional spectral processing system based on UNIX pipes
Delaglio, F., Grzesiek, S., Vuister, G., Zhu, G., Pfeifer, J., & Bax, A. (1995) · Journal of Biomolecular NMR · doi:10.1007/bf00197809 · Cited by 15,965
Cardiac excitation–contraction coupling
Bers, D. M. (2002) · Nature · doi:10.1038/415198a · Cited by 4,744
Proton-enhanced NMR of dilute spins in solids
Pines, A., Gibby, M. G., & Waugh, J. S. (1973) · The Journal of Chemical Physics · doi:10.1063/1.1680061 · Cited by 2,493
NMRFAM-SPARKY: enhanced software for biomolecular NMR spectroscopy
Lee, W., Tonelli, M., & Markley, J. L. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btu830 · Cited by 2,045
A micropeptide encoded by a putative long noncoding RNA regulates muscle performance
Anderson, D. M., Anderson, K. M., Chang, C.-L., Makarewich, C. A., Nelson, B. R., McAnally, J. R., Kasaragod, P., Shelton, J. M., Liou, J., Bassel-Duby, R., et al. (2015) · Cell · doi:10.1016/j.cell.2015.01.009 · Cited by 1,216
Phospholamban: a crucial regulator of cardiac contractility
MacLennan, D. H., & Kranias, E. G. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1151 · Cited by 1,088
A peptide encoded by a transcript annotated as long noncoding RNA enhances SERCA activity in muscle
Nelson, B. R., Makarewich, C. A., Anderson, D. M., Winders, B. R., Troupes, C. D., Wu, F., Reese, A. L., McAnally, J. R., Chen, X., Kavalali, E. T., et al. (2016) · Science · doi:10.1126/science.aad4076 · Cited by 788
Phospholamban: Protein Structure, Mechanism of Action, and Role in Cardiac Function
SIMMERMAN, H. K. B., & JONES, L. R. (1998) · Physiological Reviews · doi:10.1152/physrev.1998.78.4.921 · Cited by 574
Greenberg, B., Butler, J., Felker, G. M., Ponikowski, P., Voors, A. A., Desai, A. S., Barnard, D., Bouchard, A., Jaski, B., Lyon, A. R., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00082-9 · Cited by 525
Reconstitution of Membrane Proteins into Lipid-Rich Bilayered Mixed Micelles for NMR Studies
Sanders, C. R., & Landis, G. C. (1995) · Biochemistry · doi:10.1021/bi00012a022 · Cited by 388
Nmrglue: an open source Python package for the analysis of multidimensional NMR data
Helmus, J. J., & Jaroniec, C. P. (2013) · Journal of Biomolecular NMR · doi:10.1007/s10858-013-9718-x · Cited by 383
The Magic of Bicelles Lights Up Membrane Protein Structure
Dürr, U. H. N., Gildenberg, M., & Ramamoorthy, A. (2012) · Chemical Reviews · doi:10.1021/cr300061w · Cited by 362
Abnormalities of Calcium Cycling in the Hypertrophied and Failing Heart
Houser, S. R., Piacentino III, V., & Weisser, J. (2000) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2000.1206 · Cited by 330
Andronesi, O. C., Becker, S., Seidel, K., Heise, H., Young, H. S., & Baldus, M. (2005) · Journal of the American Chemical Society · doi:10.1021/ja0530164 · Cited by 325
A solid-state NMR Index of helical membrane protein structure and topology
Marassi, F. M., & Opella, S. J. (2000) · Journal of Magnetic Resonance · doi:10.1006/jmre.2000.2035 · Cited by 310
Separated local field spectra in NMR: determination of structure of solids
Hester, R. K., Ackerman, J. L., Neff, B. L., & Waugh, J. S. (1976) · Physical Review Letters · doi:10.1103/physrevlett.36.1081 · Cited by 310
The sarcoplasmic Ca2+-ATPase: design of a perfect chemi-osmotic pump
Møller, J. V., Olesen, C., Winther, A.-M. L., & Nissen, P. (2010) · Quarterly Reviews of Biophysics · doi:10.1017/s003358351000017x · Cited by 284
Imaging membrane protein helical wheels
Wang, J., Denny, J., Tian, C., Kim, S., Mo, Y., Kovacs, F., Song, Z., Nishimura, K., Gan, Z., Fu, R., et al. (2000) · Journal of Magnetic Resonance · doi:10.1006/jmre.2000.2037 · Cited by 278
Ca2+ signalling and muscle disease
MacLennan, D. H. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01566.x · Cited by 238
Widespread control of calcium signaling by a family of SERCA-inhibiting micropeptides
Anderson, D. M., Makarewich, C. A., Anderson, K. M., Shelton, J. M., Bezprozvannaya, S., Bassel-Duby, R., & Olson, E. N. (2016) · Science Signaling · doi:10.1126/scisignal.aaj1460 · Cited by 224
Bechinger, B., Kim, Y., Chirlian, L. E., Gesell, J. J., Neumann, J., Montal, M., Tomich, J. M., ZASLOFF, M. A., & Opella, S. J. (1991) · Journal of Biomolecular NMR · doi:10.1007/bf01877228 · Cited by 196
Traaseth, N. J., Shi, L., Verardi, R., Mullen, D. G., Barany, G., & Veglia, G. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904290106 · Cited by 193
Self-citationGor’kov, P. L., Chekmenev, E. Y., Li, C., Cotten, M., Buffy, J. J., Traaseth, N. J., Veglia, G., & Brey, W. W. (2007) · Journal of Magnetic Resonance · doi:10.1016/j.jmr.2006.11.008 · Cited by 192
Self-citationVerardi, R., Shi, L., Traaseth, N. J., Walsh, N., & Veglia, G. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016535108 · Cited by 180
Self-citationAltered sarcoplasmic reticulum calcium cycling—targets for heart failure therapy
Kho, C., Lee, A., & Hajjar, R. J. (2012) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2012.145 · Cited by 175
15N chemical shift referencing in solid state NMR
Bertani, P., Raya, J., & Bechinger, B. (2014) · Solid State Nuclear Magnetic Resonance · doi:10.1016/j.ssnmr.2014.03.003 · Cited by 165
Three-dimensional crystals of CaATPase from sarcoplasmic reticulum. Symmetry and molecular packing
Stokes, D. L., & Green, N. M. (1990) · Biophysical Journal · doi:10.1016/s0006-3495(90)82501-7 · Cited by 162
Ram, P., & Prestegard, J. H. (1988) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(88)90203-9 · Cited by 154
Allosteric regulation of SERCA by phosphorylation-mediated conformational shift of phospholamban
Gustavsson, M., Verardi, R., Mullen, D. G., Mote, K. R., Traaseth, N. J., Gopinath, T., & Veglia, G. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303006110 · Cited by 150
Self-citationSelective averaging for high-resolution solid-state NMR spectroscopy of aligned samples
Nevzorov, A. A., & Opella, S. J. (2007) · Journal of Magnetic Resonance · doi:10.1016/j.jmr.2006.09.006 · Cited by 148
The Structural Basis for Phospholamban Inhibition of the Calcium Pump in Sarcoplasmic Reticulum
Akin, B. L., Hurley, T. D., Chen, Z., & Jones, L. R. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.501585 · Cited by 145
Protein-phospholipid interplay revealed with crystals of a calcium pump
Norimatsu, Y., Hasegawa, K., Shimizu, N., & Toyoshima, C. (2017) · Nature · doi:10.1038/nature22357 · Cited by 145
Packing of apolar side chains enables accurate design of highly stable membrane proteins
Mravic, M., Thomaston, J. L., Tucker, M., Solomon, P. E., Liu, L., & DeGrado, W. F. (2019) · Science · doi:10.1126/science.aav7541 · Cited by 140
Makarewich, C. A., Munir, A. Z., Schiattarella, G. G., Bezprozvannaya, S., Raguimova, O. N., Cho, E. E., Vidal, A. H., Robia, S. L., Bassel-Duby, R., & Olson, E. N. (2018) · eLife · doi:10.7554/elife.38319 · Cited by 136
Self-citationKaye, D. M., Preovolos, A., Marshall, T., Byrne, M., Hoshijima, M., Hajjar, R., Mariani, J. A., Pepe, S., Chien, K. R., & Power, J. M. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.03.047 · Cited by 125
When detergent meets bilayer: Birth and coming of age of lipid bicelles
Dürr, U. H. N., Soong, R., & Ramamoorthy, A. (2013) · Progress in Nuclear Magnetic Resonance Spectroscopy · doi:10.1016/j.pnmrs.2013.01.001 · Cited by 124
Phosphorylation-dependent conformational switch in spin-labeled phospholamban bound to SERCA
Karim, C. B., Zhang, Z., Howard, E. C., Torgersen, K. D., & Thomas, D. D. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.02.051 · Cited by 106
Spectroscopic validation of the pentameric structure of phospholamban
Traaseth, N. J., Verardi, R., Torgersen, K. D., Karim, C. B., Thomas, D. D., & Veglia, G. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701016104 · Cited by 100
Self-citationZvaritch, E., Backx, P. H., Jirik, F. R., Kimura, Y., de Leon, S., Schmidt, A. G., Hoit, B. D., Lester, J. W., Kranias, E. G., & MacLennan, D. H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.20.14985 · Cited by 97
Ha, K. N., Masterson, L. R., Hou, Z., Verardi, R., Walsh, N., Veglia, G., & Robia, S. L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013987108 · Cited by 91
Self-citationOrientations of helical peptides in membrane bilayers by solid state NMR spectroscopy
Bechinger, B., Gierasch, L. M., Montal, M., ZASLOFF, M. A., & Opella, S. J. (1996) · Solid State Nuclear Magnetic Resonance · doi:10.1016/0926-2040(95)01224-9 · Cited by 86
Rijdt, W. P. T., van Tintelen, J. P., Vink, A., van der Wal, A. C., de Boer, R. A., van den Berg, M. P., & Suurmeijer, A. J. H. (2016) · Histopathology · doi:10.1111/his.12963 · Cited by 80
Rathod, N., Bak, J. J., Primeau, J. O., Fisher, M. E., Espinoza-Fonseca, L. M., Lemieux, M. J., & Young, H. S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168891 · Cited by 71
Phospholamban Binds with Differential Affinity to Calcium Pump Conformers
Bidwell, P., Blackwell, D. J., Hou, Z., Zima, A. V., & Robia, S. L. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.266759 · Cited by 69
Self-citationSerine 16 phosphorylation induces an order-to-disorder transition in monomeric phospholamban
Metcalfe, E. E., Traaseth, N. J., & Veglia, G. (2005) · Biochemistry · doi:10.1021/bi047571e · Cited by 66
Self-citationCeholski, D. K., Trieber, C. A., & Young, H. S. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.360859 · Cited by 63
Gustavsson, M., Traaseth, N. J., Karim, C. B., Lockamy, E. L., Thomas, D. D., & Veglia, G. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.03.015 · Cited by 63
Self-citationWasala, N. B., Yue, Y., Lostal, W., Wasala, L. P., Niranjan, N., Hajjar, R. J., Babu, G. J., & Duan, D. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2019.12.011 · Cited by 63
Karim, C. B., Marquardt, C. G., Stamm, J. D., Barany, G., & Thomas, D. D. (2000) · Biochemistry · doi:10.1021/bi0003543 · Cited by 59
Gopinath, T., & Veglia, G. (2009) · Journal of the American Chemical Society · doi:10.1021/ja900096d · Cited by 57
Self-citationLethal, Hereditary Mutants of Phospholamban Elude Phosphorylation by Protein Kinase A
Ceholski, D. K., Trieber, C. A., Holmes, C. F. B., & Young, H. S. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.382713 · Cited by 57
Gustavsson, M., Traaseth, N. J., & Veglia, G. (2012) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2011.07.040 · Cited by 55
Self-citationHa, K. N., Traaseth, N. J., Verardi, R., Zamoon, J., Cembran, A., Karim, C. B., Thomas, D. D., & Veglia, G. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704056200 · Cited by 55
Self-citationKho, C. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1185261 · Cited by 54
Defining the molecular components of calcium transport regulation in a reconstituted membrane system
Reddy, L. G., Cornea, R. L., Winters, D. L., McKenna, E., & Thomas, D. D. (2003) · Biochemistry · doi:10.1021/bi026995a · Cited by 53
(2005) · doi:10.1021/bi0478446 · Cited by 52
Self-citationWeber, D. K., Reddy, U. V., Wang, S., Larsen, E. K., Gopinath, T., Gustavsson, M. B., Cornea, R. L., Thomas, D. D., De Simone, A., & Veglia, G. (2021) · eLife · doi:10.7554/elife.66226 · Cited by 51
Self-citationGene Therapy With the DWORF Micropeptide Attenuates Cardiomyopathy in Mice
Makarewich, C. A., Bezprozvannaya, S., Gibson, A. M., Bassel-Duby, R., & Olson, E. N. (2020) · Circulation Research · doi:10.1161/circresaha.120.317156 · Cited by 50
Eijgenraam, T. R., Boogerd, C. J. J., Stege, N. M., Teixeira, V. O. N., Dokter, M. M., Schmidt, L. E., Yin, X., Theofilatos, K., Mayr, M., van der Meer, P., et al. (2021) · Circulation Heart Failure · doi:10.1161/circheartfailure.121.008532 · Cited by 46
The Phospholamban Pentamer Alters Function of the Sarcoplasmic Reticulum Calcium Pump SERCA
Glaves, J. P., Primeau, J. O., Espinoza‐Fonseca, L. M., Lemieux, M. J., & Young, H. S. (2019) · Biophysical Journal · doi:10.1016/j.bpj.2019.01.013 · Cited by 43
Morales, E. D., Yue, Y., Watkins, T. B., Han, J.-Y., Pan, X., Gibson, A. M., Hu, B., Brito‐Estrada, O., Yao, G., Makarewich, C. A., et al. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.122.027480 · Cited by 36
The transmembrane peptide DWORF activates SERCA2a via dual mechanisms
Li, A., Yuen, S. L., Stroik, D. R., Kleinboehl, E., Cornea, R. L., & Thomas, D. D. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100412 · Cited by 35
Sensitivity Enhancement of Separated Local Field Experiments: Application to Membrane Proteins
Gopinath, T., Verardi, R., Traaseth, N. J., & Veglia, G. (2010) · The Journal of Physical Chemistry B · doi:10.1021/jp909778a · Cited by 34
Self-citationDe Simone, A., Gustavsson, M., Montalvao, R. W., Shi, L., Veglia, G., & Vendruscolo, M. (2013) · Biochemistry · doi:10.1021/bi400517b · Cited by 32
Self-citationAbu‐Baker, S., Lu, J., Chu, S., Shetty, K. K., Gor′kov, P. L., & Lorigan, G. A. (2007) · Protein Science · doi:10.1110/ps.072977707 · Cited by 31
Vostrikov, V. V., Soller, K. J., Ha, K. N., Gopinath, T., & Veglia, G. (2015) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2014.09.007 · Cited by 29
Self-citationMonomeric phospholamban overexpression in transgenic mouse hearts
Chu, G., Dorn, G. W., Luo, W., Harrer, J. M., Kadambi, V. J., Walsh, R. A., & Kranias, E. G. (1997) · Circulation Research · doi:10.1161/01.res.81.4.485 · Cited by 29
Phospholamban pentamerization increases sensitivity and dynamic range of cardiac relaxation
Funk, F., Kronenbitter, A., Hackert, K., Oebbeke, M., Klebe, G., Barth, M., Koch, D., & Schmitt, J. P. (2023) · Cardiovascular Research · doi:10.1093/cvr/cvad037 · Cited by 28
SERCA2a Protein Levels Are Unaltered in Human Heart Failure
Ragone, I., Barallobre-Barreiro, J., Takov, K., Theofilatos, K., Yin, X., Schmidt, L. E., Domenech, N., Crespo-Leiro, M. G., van der Voorn, S. M., Vink, A., et al. (2023) · Circulation · doi:10.1161/circulationaha.123.064513 · Cited by 27
Ha, K. N., Gustavsson, M., & Veglia, G. (2012) · Journal of Muscle Research and Cell Motility · doi:10.1007/s10974-012-9319-4 · Cited by 27
Self-citationWang, H., & Zuiderweg, E. P. (1995) · Journal of Biomolecular NMR · doi:10.1007/bf00208812 · Cited by 26
Sarcoplasmic reticulum calcium mishandling: central tenet in heart failure?
Denniss, A. L., Dashwood, A. M., Molenaar, P., & Beard, N. A. (2020) · Biophysical Reviews · doi:10.1007/s12551-020-00736-y · Cited by 26
Cleary, S. R., Fang, X., Cho, E. E., Pribadi, M. P., Seflova, J., Beach, J. R., Kekenes-Huskey, P. M., & Robia, S. L. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102060 · Cited by 26
Self-citationA Large-Scale High-Throughput Screen for Modulators of SERCA Activity
Bidwell, P. A., Yuen, S. L., Li, J., Berg, K. G., Rebbeck, R. T., Aldrich, C. C., Roopnarine, O., Cornea, R. L., & Thomas, D. D. (2022) · Biomolecules · doi:10.3390/biom12121789 · Cited by 26
Sakai, H., Ikeda, Y., Honda, T., Tanaka, Y., Shiraishi, K., & Inui, M. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.09.006 · Cited by 24
Blocking phospholamban with VHH intrabodies enhances contractility and relaxation in heart failure
Genst, E. D., Foo, K. S., Xiao, Y., Rohner, E., de Vries, E., Sohlmér, J., Witman, N., Hidalgo, A., Kolstad, T. R., Louch, W. E., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29703-9 · Cited by 22
A kink in DWORF helical structure controls the activation of the sarcoplasmic reticulum Ca2+-ATPase
Reddy, U. V., Weber, D. K., Wang, S., Larsen, E. K., Gopinath, T., De Simone, A., Robia, S., & Veglia, G. (2022) · Structure · doi:10.1016/j.str.2021.11.003 · Cited by 21
Self-citationRakovskaya, A., Erofeev, A., Vinokurov, E. K., Pchitskaya, E. I., Dahl, R. S., & Борисович, Б. И. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241813973 · Cited by 21
In Vitro Selection and Characterization of DNA Aptamers Specific for Phospholamban
Tanaka, Y., Honda, T., Matsuura, K., Kimura, Y., & Inui, M. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.149526 · Cited by 20
Soller, K. J., Yang, J., Veglia, G., & Bowser, M. T. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.738807 · Cited by 20
Self-citationGhimire, H., Abu-Baker, S., Sahu, I. D., Zhou, A., Mayo, D. J., Lee, R. T., & Lorigan, G. A. (2012) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2011.11.030 · Cited by 19
Roopnarine, O., Yuen, S. L., Thompson, A. R., Roelike, L. N., Rebbeck, R. T., Bidwell, P. A., Aldrich, C. C., Cornea, R. L., & Thomas, D. D. (2023) · Scientific Reports · doi:10.1038/s41598-023-37704-x · Cited by 19
Al-Abdul-Wahid, M. S., Verardi, R., Veglia, G., & Prosser, R. S. (2011) · Journal of Biomolecular NMR · doi:10.1007/s10858-011-9551-z · Cited by 18
Self-citationYu, X., & Lorigan, G. A. (2014) · The Journal of Physical Chemistry B · doi:10.1021/jp500316s · Cited by 16
Nelson, S. E. D., Ha, K. N., Gopinath, T., Exline, M. H., Mascioni, A., Thomas, D. D., & Veglia, G. (2018) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2018.02.030 · Cited by 16
Self-citationKoroloff, S. N., & Nevzorov, A. A. (2015) · Journal of Magnetic Resonance · doi:10.1016/j.jmr.2015.03.016 · Cited by 12
Soller, K. J., Verardi, R., Jing, M., Abrol, N., Yang, J., Walsh, N., Vostrikov, V. V., Robia, S. L., Bowser, M. T., & Veglia, G. (2015) · Scientific Reports · doi:10.1038/srep13000 · Cited by 12
Self-citationWeber, D. K., Wang, S., Markley, J. L., Veglia, G., & Lee, W. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btaa019 · Cited by 11
Self-citationSaad, A., & Bechinger, B. (2023) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2023.184162 · Cited by 11
Nikolaienko, R. M., Bovo, E., Yuen, S. L., Treinen, L. M., Berg, K. G., Aldrich, C. C., Thomas, D. D., Cornea, R. L., & Zima, A. V. (2022) · Biophysical Journal · doi:10.1016/j.bpj.2022.12.002 · Cited by 9
Hughes, E., Edwards, R., & Middleton, D. A. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.09.056 · Cited by 6
Unleashing the Power of Genetics: PLN Ablation, Phospholambanopathies and Evolving Challenges
Mattiazzi, A., & Kranias, E. G. (2024) · Circulation Research · doi:10.1161/circresaha.123.323053 · Cited by 6
Tilgmann, C., Pollesello, P., Ovaska, M., Kaivola, J., Pystynen, J., Tiainen, E., Yliperttula, M. L., Annila, A., & Levijoki, J. M. (2012) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2012.01409.x · Cited by 5
Rathod, N., Guerrero‐Serna, G., Young, H. S., & Espinoza‐Fonseca, L. M. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2023.119613 · Cited by 4
Weber, D. K., Larsen, E. K., Gopinath, T., & Veglia, G. (2020) · Solid-State NMR · doi:10.1088/978-0-7503-2532-5ch12 · Cited by 3
Self-citationFunctional Role of an Unusual Transmembrane Acidic Residue in the Calcium Pump Regulator Myoregulin
Liu, A. Y., Rathod, N., Guerrero-Serna, G., Young, H. S., & Espinoza-Fonseca, L. M. (2023) · Biochemistry · doi:10.1021/acs.biochem.3c00026 · Cited by 3
Thompson, B. R., Soller, K. J., Vetter, A., Yang, J., Veglia, G., Bowser, M. T., & Metzger, J. M. (2019) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2019.02.016 · Cited by 2
Self-citation
Research works printed but not linked: 1
- Weber, 2021, Structural basis for allosteric control of the SERCA-phospholamban membrane complex by Ca2+ and cAMP-dependent phosphorylation, Elife, 10, 10.7554/elife.66226 · DOI · Paper page
Cited by
Solid-State NMR Approaches to Study Protein Structure and Protein–Lipid Interactions
Aisenbrey, C., Salnikov, E. S., Raya, J., Michalek, M., & Bechinger, B. (2012) · Methods in molecular biology · doi:10.1007/978-1-0716-5054-7_24 · Cited by 37
Viskupičová, J., & Espinoza-Fonseca, M. (2025) · Journal of Molecular Biology · doi:10.1016/j.jmb.2025.169200 · Cited by 23
Cullen, M., Biancaniello, C., Taškova, K., Miletić, V., Mercadante, D., & Simone, A. D. (2026) · Journal of the American Chemical Society · doi:10.1021/jacs.5c22987 · Cited by 6
Genetic landscape of phospholamban cardiomyopathies
Vafiadaki, E., Chaudhari, I., Soliman, K. M., Eliopoulos, A. G., Kranias, E. G., & Sanoudou, D. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1626242 · Cited by 5
Šeflová, J., Fang, X., Kekenes-Huskey, P. M., Espinoza‐Fonseca, L. M., Bossuyt, J., & Robia, S. L. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05123-w · Cited by 3
Self-citation
Metadata
- Authors
- Weber, D. K., Reddy, U. V., Robia, S. L., & Veglia, G.
- Affiliations
- University of Minnesota (US)
- Loyola University Chicago (US)
- Corresponding author
- Veglia, Gianluigi
- Venue
- Biochimica et Biophysica Acta (BBA) - Biomembranes
- Publisher
- Elsevier BV
- Published
- 2024-10
- Volume
- 1866
- Issue
- 7
- Pages
- 184370
- ISSN
- 0005-2736 (ISSN-L)
- PMC
- PMC11457527
- OpenAlex
- W4400478201
- Semantic Scholar
- 7c4e2a41ad954ea5628d9757ddf92fbc258e4286
- Cited by
- 8
- References
- 98
- Citations by year
- 2026: 3 · 2025: 4
- FWCI
- 1.85
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 365 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- Biochimica et Biophysica Acta (BBA) - Biomembranes (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- Funders
- National Institutes of Health (HL144130)
- AHA (19POST34420009)
- NHLBI (HL143816, HL092321)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Keywords
- phospholamban, SERCA, dilated cardiomyopathy, missense mutations, cytoplasmic domain, transmembrane domain, protein topology, protein dynamics, allosteric regulation, protein phosphorylation, Ser16 phosphorylation, protein kinase A, calcium affinity, cardiac contractility
- MeSH terms
- Phospholamban, Animals, Binding Sites, Calcium, Calcium-Binding Proteins, Cytoplasm, Humans, Mutation, Phosphorylation, Protein Binding, Sarcoplasmic Reticulum Calcium-Transporting ATPases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-18, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-18 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.